# IGC Pharma, Inc.: Form 10-K for the period ended Mar 31, 2012

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 10-K
- Filed: 2012-07-16
- Accepted by EDGAR: Jul 16, 2012, 17:06 ET
- Period: 2012-03-31
- Accession: 0001185185-12-001484
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518512001484/indiaglobal10k033112.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518512001484/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2011-04-01 to 2012-03-31 | $4.2m | us-gaap:Revenues |
| Cost of revenue | 12 months, 2011-04-01 to 2012-03-31 | $4.8m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 12 months, 2011-04-01 to 2012-03-31 | $4.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2011-04-01 to 2012-03-31 | −$7.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2011-04-01 to 2012-03-31 | $984.0k | us-gaap:InterestExpense |
| Income tax | 12 months, 2011-04-01 to 2012-03-31 | $172.8k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2011-04-01 to 2012-03-31 | −$7.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2011-04-01 to 2012-03-31 | −$0.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2011-04-01 to 2012-03-31 | −$0.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2011-04-01 to 2012-03-31 | 29,089,358 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2011-04-01 to 2012-03-31 | −$5.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2011-04-01 to 2012-03-31 | $5.5k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-03-31 | $562.9k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-03-31 | $5.2m | us-gaap:AssetsCurrent |
| Total assets | at 2012-03-31 | $25.3m | us-gaap:Assets |
| Current liabilities | at 2012-03-31 | $4.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-03-31 | $9.4m | us-gaap:Liabilities |
| Short-term borrowings | at 2012-03-31 | $210.0k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2012-03-31 | $14.8m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518512001484/indiaglobal10k033112.htm

Filed Jul 16, 2012.
Source: SEC EDGAR, the filing index for accession 0001185185-12-001484. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
